ArticleBMC gastroenterology2026
Association between the blood urea nitrogen to albumin ratio and all-cause mortality in critically ill patients with liver cirrhosis.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prognosis for critically ill patients with liver cirrhosis in the intensive care unit (ICU) remains uncertain. This study aimed to investigate the association between the Blood Urea Nitrogen to Albumin Ratio (BAR) at ICU admission and mortality in patients with liver cirrhosis.
methodsA retrospective cohort study was conducted using data from the MIMIC-IV database. The primary and secondary outcomes were 28-day and 180-day all-cause mortality after ICU admission, respectively. Patients were stratified into high- and low-BAR groups based on an optimal cutoff value determined by ROC analysis. To evaluate the association between BAR and all-cause mortality, we employed multivariate Cox regression models with comprehensive covariate adjustments. The survival experience stratified by BAR was visualized using Kaplan-Meier curves. Furthermore, we utilized restricted cubic splines to examine the potential non-linear relationship between BAR and the risk of mortality, complemented by interaction and subgroup analyses to assess the consistency of this association.
resultsA total of 3,268 adult patients with liver cirrhosis were included. The optimal BAR cutoff was 9.25. Compared to the low-BAR group, patients in the high-BAR group (≥ 9.25) had significantly higher 28-day (46.5% vs. 17.5%) and 180-day (54.0% vs. 24.9%) mortality rates. After multivariable adjustment, a high BAR remained independently associated with increased risks of 28-day (HR: 1.65, 95% CI: 1.42-1.92) and 180-day mortality (HR: 1.41, 95% CI: 1.21-1.64). BAR demonstrated good predictive ability for both 28-day mortality (AUC: 0.752) and 180-day mortality (AUC: 0.744), which was comparable to APS III and significantly better than SOFA, OASIS, GCS, and Charlson scores. Restricted cubic spline analyses revealed the mortality risk increased only modestly at BAR levels below approximately 9.25, but rose steeply and nonlinearly once BAR exceeded this threshold, indicating a potential threshold effect.
conclusionThe BAR is an independent predictor of short-and long-term mortality in critically ill cirrhotic patients. Its calculation at ICU admission may serve as a potential tool for early risk stratification, potentially facilitating timely clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.